Co-Authors
This is a "connection" page, showing publications co-authored by Giustino Parruti and Giulia Rizzo.
Connection Strength
0.281
-
Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation. Int J Infect Dis. 2020 Nov; 100:421-424.
Score: 0.224
-
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19. Eur J Intern Med. 2021 01; 83:34-38.
Score: 0.057